♟️ Wednesday 19 February 2025 Wed, 19 Feb 2025

Santos Limited's 2024 Annual Report reveals a 5% drop in production and a 9% fall in sales revenue, offset by progress in carbon capture and storage projects and emissions reductions. The company posted a net profit of $1.224 billion, down 14% from 2023.

Goodman Group reports a robust 8% increase in 1H25 operating profit to $1.22 billion and launches a $4 billion equity placement to fund its ambitious data centre growth strategy across global metro hubs.

Goodman Group delivered a robust half-year performance with operating profit up 8.4% and statutory profit swinging to a $799.8 million gain. The industrial property giant also announced a $4 billion equity raise to fuel its expanding data centre and logistics developments.

Cleanaway Waste Management Limited reported a robust first half of FY25 with double-digit EBIT growth and margin expansion, reinforcing confidence in meeting FY25 guidance and ambitious FY26 targets despite operational challenges.

Corporate Travel Management Limited reported strong half-year results for the period ending December 31, 2024, with significant EBITDA growth and effective capital management, returning $52.3 million to shareholders. The company sets ambitious FY25 and FY26 targets focused on sustainable profit growth and market share expansion.

Iluka Resources reported a 32% drop in net profit after tax to $231 million for 2024, while securing critical funding for its Eneabba rare earths refinery and progressing the Balranald mine development.

EBOS Group Limited announces the retirement of CEO John Cullity after a decade of strong growth, appointing Adam Hall as his successor to lead the company’s next phase of expansion.

EBOS Group Limited’s interim results for H1 2025 reveal a notable decrease in revenue and profit compared to the prior year, yet the company maintains its interim dividend, signaling confidence despite headwinds.

EBOS Group Limited posted a strong half-year performance with underlying EBITDA up 7.1% to $291 million, driven by growth in healthcare and animal care segments, while maintaining its interim dividend amid the loss of the Chemist Warehouse contract.

Fletcher Building reported a challenging HY25 with a 7% revenue decline and a net loss of NZ$134 million, while executing a $700 million equity raise to strengthen its balance sheet and advancing significant cost reduction initiatives.